Difference between revisions of "TC99m Biomarker Committee"
Jump to navigation
Jump to search
m |
|||
| Line 8: | Line 8: | ||
==Recent Meetings/Call Summaries== | ==Recent Meetings/Call Summaries== | ||
| + | |||
| + | *[[Media:2018_09-11_QIBA_SPECT_TC99M_Call Summary-FINAL.pdf | September 11, 2018]] | ||
| + | *[[Media:2018_08-14_QIBA_SPECT_TC99M_Call Summary-FINAL.pdf | August 14, 2018]] | ||
*[[Media:2018_07-10_QIBA_SPECT_TC99M_Call Summary-FINAL.pdf | July 10, 2018]] | *[[Media:2018_07-10_QIBA_SPECT_TC99M_Call Summary-FINAL.pdf | July 10, 2018]] | ||
| − | |||
| − | |||
==Profile Development== | ==Profile Development== | ||
Revision as of 18:05, 19 September 2018
- Co-chairs: Yuni Dewaraja, PhD; Robert Miyaoka, PhD
- Secretary: Julie Lisiecki
Full name of biomarker committee: Technetium-99m for body, oncology, and immunology